Jul 2026· Ophthalmic Surgery Lasers and Imaging Retina· Vol 57, pp.
1-5
· 0 citations· 14 references
Medicine
TL;DR
Elevated IGF-1 levels in CSCR patients suggest that this growth factor may contribute to disease pathogenesis through mechanisms involving choroidal vascular permeability and retinal endothelial activity.
Abstract
Background
AND
Objective
This study aimed to investigate serum levels of insulin-like growth factor-1 (IGF-1) and its association with parameters related to insulin resistance, in patients diagnosed with central serous chorioretinopathy (CSCR).
PATIENTS AND
Methods
In this cross-sectional comparative study, patients were classified as simple (n = 30) or complex (n = 25) CSCR based on multimodal imaging findings. Following a comprehensive ophthalmologic examination, fasting venous blood samples were collected for the biochemical analysis of glucose, insulin, IGF-1, C-reactive protein (CRP), and glycated hemoglobin (HbA1c). Subsequently, body mass index (BMI) and Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) values were calculated for each participant.
Results
Mean serum IGF-1 levels were significantly higher in simple and complex CSCR groups compared with controls (P < .05). No significant differences were observed among the groups in glucose, HbA1c, CRP, BMI, or HOMA-IR (P > .05).
Conclusion
Elevated IGF-1 levels in CSCR patients suggest that this growth factor may contribute to disease pathogenesis through mechanisms involving choroidal vascular permeability and retinal endothelial activity.
Findings indicate significant changes in the IGF system in patients with T1D, and changes in IGF-1 and IGF-2 levels are thought to be related to the metabolic disturbances seen in T1D.
E. M. Eltayef, K. Gharab, L. Ghannawi et al.· Diabetes mellitus· 0 citations
The current study was designed to explore the association between growth hormone (GH), insulin-like growth factor-1 (IGF-1), and vitamin D with the cause and development of diabetic retinopathy (DR) in Iraqi patients. The study included ninety males, separated into two categories.: Thirty controls and sixty patients (3...
Maha R. Ghreeb, M. Q. Al-Ani, Huda M. Mahmood· Iraqi Journal of Science· 0 citations
C-peptide can be used as an appropriate index for identifying IR in T2DM patients with complications and illustrated the clinical utility of C-peptide in microvascular complications such as diabetic nephropathy and diabetic retinopathy.
K. Siddiqui, S. S. Joy, S. Nawaz et al.· Medicine· 0 citations
Teprotumumab N01 treatment was associated with a substantial, early, and broadly reversible increase in circulating IGF-1 in patients with moderate-to-severe TED, but IGF-1 dynamics did not serve as an independent indicator of glycemic deterioration.
Wei Zhao, Lingli Zhou, Ying Gao et al.· Frontiers in Endocrinology· 0 citations
Serum FGF19 levels are independently associated with DKD status in T2D patients; the serum FGF19 level is decreased in T2D patients but relatively elevated in those with DKD, though the modest effect sizes and study design limit causal interpretation.